Sonoma Biotherapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.sonomabio.com
Clinical Trials
3
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
- First Posted Date
- 2024-04-12
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Sonoma Biotherapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06361836
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Sonoma Biotherapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06201416
- Locations
- 🇺🇸
UCSF Medical Center, San Francisco, California, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Mayo Clinic, Scottsdale, Arizona, United States
Study of Single Doses of SBT115301 in Healthy Participants
- First Posted Date
- 2022-05-24
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Sonoma Biotherapeutics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05388981
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
News
No news found